Factors leading to supranormal cardiac index in pediatric pulmonary hypertension patients treated with parenteral prostanoid therapy

Bibliographic Details
Title: Factors leading to supranormal cardiac index in pediatric pulmonary hypertension patients treated with parenteral prostanoid therapy
Authors: Kimberley G. Miles, Paul J. Critser, Patrick D. Evers, Michelle Cash, Melissa Magness, Elizabeth Geers, Meredith O'Neil, Zhiqian Gao, Nicholas J. Ollberding, Russel Hirsch
Source: Pulmonary Circulation, Vol 13, Iss 3, Pp n/a-n/a (2023)
Publisher Information: Wiley, 2023.
Publication Year: 2023
Collection: LCC:Diseases of the circulatory (Cardiovascular) system
LCC:Diseases of the respiratory system
Subject Terms: cardiac index, outcomes, pediatric pulmonary hypertension, prostacyclin, systemic vascular resistance, Diseases of the circulatory (Cardiovascular) system, RC666-701, Diseases of the respiratory system, RC705-779
More Details: Abstract Parenteral prostanoid therapy (PPT) can result in supranormal cardiac index (SCI; >4 L/min/m2) in pediatric pulmonary hypertension (PPH) patients. We evaluated the incidence, hemodynamic factors, and outcomes associated with SCI in PPH. This retrospective cohort study included 22 PPH patients on PPT from 2005 to 2020. Hemodynamic profiles were compared between the baseline and 3–6 month follow‐up catheterization in the SCI and non‐SCI cohorts. Cox regression analysis examined time to composite adverse outcome (CAO; Potts shunt, lung transplant, or death) controlling for initial disease severity. SCI developed in 17 (77%) patients, of whom 11 (65%) developed SCI within 6 months. The SCI cohort was characterized by significant augmentation of cardiac index (CI) and stroke volume (SV) as well as reductions in systemic vascular resistance (SVR) and pulmonary vascular resistance (PVR). Conversely, the non‐SCI cohort had unchanged SV despite a modest rise in CI as well as persistent vasoconstriction. After median follow‐up of 4.3 years (range 0.2–13 years), non‐SCI patients were at significantly increased risk for the CAO (5/5: three deaths, two Potts shunts) compared with SCI patients (5/17: two deaths, three lung transplants; adjusted hazard ratio 14.0 [95% confidence interval: 2.1–91.3], p
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2045-8940
Relation: https://doaj.org/toc/2045-8940
DOI: 10.1002/pul2.12264
Access URL: https://doaj.org/article/01762c3e44ea4aa1bc5d969c643d71d5
Accession Number: edsdoj.01762c3e44ea4aa1bc5d969c643d71d5
Database: Directory of Open Access Journals
More Details
ISSN:20458940
DOI:10.1002/pul2.12264
Published in:Pulmonary Circulation
Language:English